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Letters to the Editor
Fig. 1. Representative Western immunoblots. (A) collagen type 
I, (B) fibronectin, (C) endothelin-1, and (D) beta-actin.
Fig. 2. Intensity of bands in Western immunoblots. Intensity of 
each band was calculated as compared with that of 0 hr time point.
Transforming growth factor-β Does Not Induce 
Endothelin-1 Secretion in Primary Cultured 
Human Tenon’s Fibroblasts
Dear Editor
Subconjunctival fibrosis is closely related to scarring after 
glaucoma filtering surgery, and transforming growth factor-
β (TGF-β) is known to play a crucial role in this scarring 
process. It induces the transformation of fibroblasts to 
myofibloblasts and the production of extracellular matrix 
(ECM) in the Tenon’s capsule. Endothelin-1 (ET-1) is 
thought to be secreted by fibroblasts and contributes to 
fibrosis in such stressed conditions. However, evidence 
regarding autocrine production of ET-1 from TGF-β
stimulated human Tenon’s fibroblasts are lacking. In the 
present study, the authors evaluated the effects of TGF-β1 
on ET-1 expression from primary cultured human Tenon’s 
fibroblasts. Our results demonstrate that TGF-β1 seemingly 
has no influence on the synthesis of ET-1 in human Tenon’s 
fibroblasts. Even though fibroblasts usually are not a major 
source of ET-1, these different cellular responses may 
implicate the characteristics of Tenon’s fibroblasts as being 
different to fibroblasts from other tissue. Studies concerning 
other intracellular signaling pathways associated with pro- 
and anti- fibrosis are also needed to confirm the similarities 
of fibroblasts from human Tenon’s capsule with that from 
other organs.
Samin Hong, MD, Chan Yun Kim, MD, Jong Bok Lee, MD, 
Iizuka Yoko, MS, Gong Je Seong, MD
Institute of Vision Research, Yonsei University College of 
Medicine, Seoul, Korea
For several decades, the mechanism associated with 
subconjunctival fibrosis has been a matter of great concern 
to glaucoma specialists because scarring affects the outcome 
after glaucoma filtering surgery. Transforming growth factor-β 
(TGF-β) is known to play an important role in this scarring 
process, and many in vitro and in vivo studies reveal topical 
anti-TGF-βantibodies blocking myofibroblastic 
transformation of fibroblasts and reducing extracellular 
matrix (ECM) production in Tenon’s capsule.1-5
Fibroblast is a type of cell that synthesizes and maintains 
the ECM of various tissues. It plays an important function 
in wound healing but can also bring about over-fibrosis. 
Accordingly, the fibrotic and anti-fibrotic mechanisms have 
been studied widely in fibroblasts from various organs 
including the lung, kidney, dermis, etc. Endothelin-1 (ET-1) 
is a vasoconstricting peptide produced primarily in the 
endothelium and seems to play a key role in vascular 
homeostasis. However, under stressed conditions, it can be 
secreted by other types of cells like cardiac myocytes and 
even fibroblasts. Regarding current thought on the association 
between the ET-1 and TGF-β, there are two contrary 
opinions; the TGF-βstimulates the autocrine production of 
ET-1 in pulmonary and placental fibroblasts but not in dermal 
fibroblasts.6-10 Because ET-1 binds to the cell surface 
receptors of fibroblasts and increases cellular proliferation 
and ECM production, TGF-βis thought to induce autocrine 
production of ET-1 in human Tenon’s fibroblasts. So, in the 
present study, the authors evaluated the effects of TGF-β1 
on ET-1 expression from primary cultured human Tenon’s 
fibroblasts.
After obtaining approval from the Institutional Review 
Board, small human Tenon’s capsule specimens were 
obtained during strabismus surgery in compliance with the 
tenets of the Declaration of Helsinki. Primary cultured human 
Tenon’s fibroblasts were stimulated with 5 ng/mL of 
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recombinant human TGF-β1 (R&D System, Inc., 
Minneapolis, MN) up to 48 hours (at 0, 1, 3, 6, 12, 24, and 
48 hours) after the initiation of TGF-β1 treatment. Whole 
cellular proteins were extracted and Western immunoblots 
was performed with primary antibodies as indicated. 
Antibodies against ET-1, collagen type I, fibronectin, and β
-actin were purchased from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA). Intensity of each band was calculated as 
compared with that of 0 hr time point, and all procedures 
were performed in triplicate.
Representative Western immunoblots are shown at Figure 
1 and the intensity data are demonstrated at Figure 2. As 
compared with control (at 0 hr), the synthesis of collagen 
type I and fibronectin increased with time by more than 3 
times. This increase was more apparent after 12 hours.. 
However, a band that represents ET-1 was hardly detected on 
all samples and it did not show any significant change. Β
eta-actin, an internal control, also was not changed. 
Our results demonstrate that TGF-β1 has no influence on 
the synthesis of ET-1 in human Tenon’s fibroblasts and the 
fibroblasts of human Tenon’s capsule seem to have no 
autocrine function for the ET-1. Even though fibroblasts 
usually are not a major source of ET-1 even in other 
extraocular tissues, these different cellular responses may 
implicate that characteristics of Tenon’s fibroblasts are different 
from fibroblasts of other tissue. Further study about their 
response to exogenous ET-1 is required and other intracellular 
signaling pathways associated with pro- and anti- fibrotic courses 
are also needed to be confirmed directly. Understanding the 
precise mechanisms of the fibrotic process may give promise to 
more successful glaucoma filtering surgery.
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